Phase I trial of oral CP-547,632 (VEGFR2) in combination with paclitaxel (P) and carboplatin (C) in advanced non-small cell lung cancer (NSCLC)
2004 ◽
Vol 22
(14_suppl)
◽
pp. 3014-3014
◽
Keyword(s):
Phase I
◽